Every round on record, with the sources behind each and the investors on them.
An AI platform for evaluating and developing drugs based on peptides
peptaris.comPhiladelphiaBiotech
2 sources · checked 2 times, last 42d ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Source 1 says individual investment amounts were not disclosed, while Source 2 specifically reports the $4 million raise; Source 2 wins. The filing fixes the announcement only to June, not a specific day.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed | $4M | ~ 2026-09-24 | not stated | No recent discussion |
2 sources · checked 2 times, last 42d ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 sources
Source 1 says individual investment amounts were not disclosed, while Source 2 specifically reports the $4 million raise; Source 2 wins. The filing fixes the announcement only to June, not a specific day. | ||||
Peptaris builds an AI platform that mines biological information to discover, design, optimize, and develop peptide medicines for therapeutic use.
Checked against 8 sources on Sep 24
Also named as backers in company research: Penn StartUP Fund